186
ORGANIC SYNTHESIS—1995
II.F.1-2 Kandzia, C. and Steckhan, E., TL, 35, 3695.
O
AgOAc, pyr
MeCN, LÌCIO4
O.
O
O
O
87%
II.F.1-3 Koch, A., Reymond, J.L., and Lerner, R.A., JACS, 116, 803.
^
MeCN, H 2 Q 2
Antibody 20B11
Ar
Ar
>98% e.e.
II.F.1-4 Jacobsen, E.N. et al., JACS, 116,425.
Non-Stereospecific Mechanisms in Asymmetric Addition to
Alkenes Result in EnantiodifTerentation after the First
Irreversible Step.
II.F.1-5 Bovicelli, P. et al., JOC, 59,4304; Yadav, V.K. and Kapoor,
K.K., TL, 35,9481; Kende, A.S. et al., TL, 35, 8123.
80%
II.F.1-6 Romeo, S. and Rich, D.H., TL, 35, 4939.
Stereoselective Synthesis of Protected Aminoalkyl Epoxides.
ORGANIC SYNTHESIS—1995
II.F.1-2 Kandzia, C. and Steckhan, E., TL, 35, 3695.
O
AgOAc, pyr
MeCN, LÌCIO4
O.
O
O
O
87%
II.F.1-3 Koch, A., Reymond, J.L., and Lerner, R.A., JACS, 116, 803.
^
MeCN, H 2 Q 2
Antibody 20B11
Ar
Ar
>98% e.e.
II.F.1-4 Jacobsen, E.N. et al., JACS, 116,425.
Non-Stereospecific Mechanisms in Asymmetric Addition to
Alkenes Result in EnantiodifTerentation after the First
Irreversible Step.
II.F.1-5 Bovicelli, P. et al., JOC, 59,4304; Yadav, V.K. and Kapoor,
K.K., TL, 35,9481; Kende, A.S. et al., TL, 35, 8123.
80%
II.F.1-6 Romeo, S. and Rich, D.H., TL, 35, 4939.
Stereoselective Synthesis of Protected Aminoalkyl Epoxides.